SugarCone Biotech will be at the International Cancer Immunotherapy Conference: Translating Science into Survival 2015

August 31, 2015immunotherapy, News, oncology, UncategorizedPaul Rennert

The SugarCone Blog is brought to you by SugarCone Biotech Consulting - Click to learn more about what we can do for your company.

Paul Rennert, Founder & Principal of SugarCone Biotech LLC, will be attending the joint CRI/AACR event: International Cancer Immunotherapy Conference: Translating Science into Survival 2015. SugarCone Biotech LLC is a consulting firm specializing in biotech strategy and investment.

The conference is in NYC Sept 16-19 and promises to be the key immunotherapy meeting of the fall conference season. Please reach out to connect with Paul at rennertp@sugarconebiotech.com.

Leave a comment or email us at rennertp@sugarconebiotech.com or info@sugarconebiotech.com, and follow @PDRennert on Twitter. Click to learn more about what SugarCone Biotech Consulting can do for your company. Cancel reply

You must be logged in to post a comment.